Barbara H McGovern

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Open forum infectious diseases

The New England journal of medicine

The Journal of infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Charles S Berenson, Bret Lashner, Louis Korman, Elizabeth Hohmann, Abhishek Deshpande, Thomas J Louie, Matthew Sims, Darrell Pardi, Colleen Kraft, Elaine E L Wang, Stuart H Cohen, Paul Feuerstadt, Caterina Oneto, Bharat Misra, John Pullman, Ananya De, Asli Memisoglu, David A Lombardi, Brooke R Hasson, Barbara H McGovern, Lisa von Moltke, Christine Lee
Prevalence of comorbid factors in patients with recurrent Clostridioides difficile infection in ECOSPOR III, a randomized trial of an oral microbiota-based therapeutic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Timothy J Straub, Mary-Jane Lombardo, Jessica A Bryant, Liyang Diao, Thomas P Lodise, Daniel E Freedberg, Jennifer Wortman, Kevin D Litcofsky, Brooke R Hasson, Barbara H McGovern, Christopher B Ford, Matthew R Henn
Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Christopher W J McChalicher, Mary-Jane Lombardo, Sahil Khanna, Gregory J McKenzie, Elizabeth M Halvorsen, Sanabel Almomani, Brian Schuster, Brooke R Hasson, Barbara H McGovern, David S Ege, John G Auniņš
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool. The Journal of infectious diseases (2023)
Christopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, Mary-Jane Lombardo, Brooke Hasson, John G Auniņš, Barbara H McGovern, David S Ege
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool. Open forum infectious diseases 9 (9) (2022)
Paul Feuerstadt, Thomas J Louie, Bret Lashner, Elaine E L Wang, Liyang Diao, Jessica A Bryant, Matthew Sims, Colleen S Kraft, Stuart H Cohen, Charles S Berenson, Louis Y Korman, Christopher B Ford, Kevin D Litcofsky, Mary-Jane Lombardo, Jennifer R Wortman, Henry Wu, John G Auniņš, Christopher W J McChalicher, Jonathan A Winkler, Barbara H McGovern, Michele Trucksis, Matthew R Henn, Lisa von Moltke
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. The New England journal of medicine 386 (3) (2022)
Barbara H McGovern, Christopher B Ford, Matthew R Henn, Darrell S Pardi, Sahil Khanna, Elizabeth L Hohmann, Edward J O'Brien, Christopher A Desjardins, Patricia Bernardo, Jennifer R Wortman, Mary-Jane Lombardo, Kevin D Litcofsky, Jonathan A Winkler, Christopher W J McChalicher, Sunny S Li, Amelia D Tomlinson, Madhumitha Nandakumar, David N Cook, Roger J Pomerantz, John G Auninš, Michele Trucksis
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (12) (2021)
Mark H Wilcox, Barbara H McGovern, Gail A Hecht
The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis. Open forum infectious diseases 7 (5) (2020)

Barbara H McGovern.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Barbara H McGovern